Prelude Capital Management’s Ocugen OCGN Stock Holding History

Prelude Capital Management’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,149	Closed	-$52.8K	–	1444
2026 Q1	$52.8K	Buy	+29,149	New	+$50.4K	﹤0.01%	1123

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Prelude Capital Management's OCGN Position: Q2 2026 in Review

Prelude Capital Management sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 29,149 shares — an estimated $52.8K sold.

Prelude Capital Management first reported a position in OCGN in Q1 2026 and held it in 1 quarter. The position peaked at $52.8K in Q1 2026. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

Prelude Capital Management reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
Prelude Capital Management sold 29,149 Ocugen shares in Q2 2026, an estimated $52.8K.
Prelude Capital Management first reported a position in Ocugen in Q1 2026 and held it in 1 quarter.
Prelude Capital Management's Ocugen position peaked at $52.8K in Q1 2026.
147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.